1. Home
  2. NVAX vs NEXT Comparison

NVAX vs NEXT Comparison

Compare NVAX & NEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • NEXT
  • Stock Information
  • Founded
  • NVAX 1987
  • NEXT 2010
  • Country
  • NVAX United States
  • NEXT United States
  • Employees
  • NVAX N/A
  • NEXT N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • NEXT Oil & Gas Production
  • Sector
  • NVAX Health Care
  • NEXT Energy
  • Exchange
  • NVAX Nasdaq
  • NEXT Nasdaq
  • Market Cap
  • NVAX 1.3B
  • NEXT 2.0B
  • IPO Year
  • NVAX 1995
  • NEXT N/A
  • Fundamental
  • Price
  • NVAX $6.84
  • NEXT $10.68
  • Analyst Decision
  • NVAX Buy
  • NEXT Buy
  • Analyst Count
  • NVAX 5
  • NEXT 1
  • Target Price
  • NVAX $16.60
  • NEXT $15.00
  • AVG Volume (30 Days)
  • NVAX 4.9M
  • NEXT 3.0M
  • Earning Date
  • NVAX 08-07-2025
  • NEXT 08-13-2025
  • Dividend Yield
  • NVAX N/A
  • NEXT N/A
  • EPS Growth
  • NVAX N/A
  • NEXT N/A
  • EPS
  • NVAX 2.97
  • NEXT N/A
  • Revenue
  • NVAX $1,254,962,000.00
  • NEXT N/A
  • Revenue This Year
  • NVAX $56.85
  • NEXT N/A
  • Revenue Next Year
  • NVAX N/A
  • NEXT N/A
  • P/E Ratio
  • NVAX $2.30
  • NEXT N/A
  • Revenue Growth
  • NVAX 25.92
  • NEXT N/A
  • 52 Week Low
  • NVAX $5.01
  • NEXT $4.27
  • 52 Week High
  • NVAX $17.81
  • NEXT $10.79
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.12
  • NEXT 74.69
  • Support Level
  • NVAX $6.54
  • NEXT $8.89
  • Resistance Level
  • NVAX $7.20
  • NEXT $9.31
  • Average True Range (ATR)
  • NVAX 0.28
  • NEXT 0.48
  • MACD
  • NVAX 0.06
  • NEXT 0.10
  • Stochastic Oscillator
  • NVAX 66.36
  • NEXT 89.92

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

Share on Social Networks: